Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12582
Title: Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios.
Austin Authors: Zhu, Xiaolin;Petrovski, Slavé;Xie, Pingxing;Ruzzo, Elizabeth K;Lu, Yi-Fan;McSweeney, K Melodi;Ben-Zeev, Bruria;Nissenkorn, Andreea;Anikster, Yair;Oz-Levi, Danit;Dhindsa, Ryan S;Hitomi, Yuki;Schoch, Kelly;Spillmann, Rebecca C;Heimer, Gali;Marek-Yagel, Dina;Tzadok, Michal;Han, Yujun;Worley, Gordon;Goldstein, Jennifer;Jiang, Yong-Hui;Lancet, Doron;Pras, Elon;Shashi, Vandana;McHale, Duncan;Need, Anna C;Goldstein, David B
Affiliation: Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA
UCB NewMedicines, Slough, UK
Center for Human Genome Variation, Duke University School of Medicine, Durham, North Carolina, USA
Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA
Center for Human Genome Variation, Duke University School of Medicine, Durham, North Carolina, USA
Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel
Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK
Department of Medicine, University of Melbourne, Austin Health and Royal Melbourne Hospital, Melbourne, Australia
Department of Neurobiology, Duke University, Durham, North Carolina, USA
Present address: Department of Human Genetics, McGill University, Montreal, Quebec, Canada
Present address: Department of Human Genetics, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Pinchas Borenstein Talpiot Medical Leadership Program, Pediatric Neurology Unit, Chaim Sheba Medical Center, Tel HaShomer, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Danek Gertner Institute of Human Genetics, Sheba Medical Center, Ramat Gan, Israel.
Metabolic Disease Unit, Edmond and Lily Children's Hospital, Sheba Medical Center, Ramat Gan, Israel.
Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Issue Date: 15-Jan-2015
Publication information: Genetics in Medicine : Official Journal of the American College of Medical Genetics 2015; 17(10): 774-81
Abstract: Purpose:Despite the recognized clinical value of exome-based diagnostics, methods for comprehensive genomic interpretation remain immature. Diagnoses are based on known or presumed pathogenic variants in genes already associated with a similar phenotype. Here, we extend this paradigm by evaluating novel bioinformatics approaches to aid identification of new gene-disease associations.Methods:We analyzed 119 trios to identify both diagnostic genotypes in known genes and candidate genotypes in novel genes. We considered qualifying genotypes based on their population frequency and in silico predicted effects we also characterized the patterns of genotypes enriched among this collection of patients.Results:We obtained a genetic diagnosis for 29 (24%) of our patients. We showed that patients carried an excess of damaging de novo mutations in intolerant genes, particularly those shown to be essential in mice (P = 3.4 × 10(-8)). This enrichment is only partially explained by mutations found in known disease-causing genes.Conclusion:This work indicates that the application of appropriate bioinformatics analyses to clinical sequence data can also help implicate novel disease genes and suggest expanded phenotypes for known disease genes. These analyses further suggest that some cases resolved by whole-exome sequencing will have direct therapeutic implications.Genet Med advance online publication 15 January 2015Genetics in Medicine (2015); doi:10.1038/gim.2014.191.
Gov't Doc #: 25590979
URI: http://ahro.austin.org.au/austinjspui/handle/1/12582
DOI: 10.1038/gim.2014.191
URL: https://pubmed.ncbi.nlm.nih.gov/25590979
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

8
checked on Nov 30, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.